Wen Bu

Keratin 6 is not essential for mammary gland development.

Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.

Lentivirus vectors for stably introducing genes into mammary epithelial cells in vivo.

Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.

EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.

Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.

Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.

Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.

Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.

STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.

Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.

Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.

Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype.

Breast tumor cell-specific knockout of inhibits cancer cell plasticity, dissemination, and lung metastasis in mice.

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.

Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.

Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo.

Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.

High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array.

Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.